ClinicalTrials.Veeva

Menu
S

Studienpraxis Urologie | Nuertingen, Germany

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Enzalutamide
Talazoparib
Abiraterone Acetate
Docetaxel

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

The purpose of this study is to evaluate the safety and efficacy of pembrolizumab (MK-3475) in the adjuvant treatment of adult participants who have...

Active, not recruiting
Renal Cell Carcinoma
Drug: Placebo
Biological: Pembrolizumab

The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men...

Active, not recruiting
Prostatic Neoplasms
Drug: Placebo
Biological: Pembrolizumab

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems